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Abstract
Background: High throughput techniques have generated a huge set of biological data, which are
deposited in various databases. Efficient exploitation of these databases is often hampered by a lack
of appropriate tools, which allow easy and reliable identification of genes that miss functional
characterization but are correlated with specific biological conditions (e.g. organotypic expression).
Results: We have developed a simple algorithm (DGSA = Database-dependent Gene Selection
and Analysis) to identify genes with unknown functions involved in organ development
concentrating on the heart. Using our approach, we identified a large number of yet
uncharacterized genes, which are expressed during heart development. An initial functional
characterization of genes by loss-of-function analysis employing morpholino injections into
zebrafish embryos disclosed severe developmental defects indicating a decisive function of selected
genes for developmental processes.
Conclusion: We conclude that DGSA is a versatile tool for database mining allowing efficient
selection of uncharacterized genes for functional analysis.
Background
In recent years, the advent of high-throughput analytical
techniques, such as microarrays and serial analysis of gene
expression (SAGE), has led to a rapid accumulation of
biological data. The large size of databases, which are now
within the petabytes range [1] precludes manual analysis
and renders unsystematic approaches obsolete. To cope
with these new challenges and to facilitate efficient data
analyses, numerous academic and commercial software
packages and databases have been developed [2-5]. Yet,
genes to which no biological function has been assigned
compromise the usability of these data. In particular, the
construction of linear and non-linear models has proven
to be difficult if "function unknown genes" are included
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[6]. Any attempts to integrate and analyze complex bio-
logical data from various "omics" techniques (e.g. tran-
scriptomics, proteomics, and metabolomics) to
understand biological phenomena as a collection of inter-
connected systems will depend on the functional annota-
tion of the majority of their components [7]. Thus,
successful approaches to "Systems Biology" will depend
on the identification and functional characterization of
most if not all players in the system under study [8,9]. An
obvious, almost trivial conclusion is the systematic iden-
tification of only those genes, which lack biologically
valid annotations, followed by functional characteriza-
tion. Surprisingly, only few attempts were made to
address this problem systematically although most data-
bases contain large numbers of genes, which have only
been identified by computational sequence analyses
[10,11]. Instead, most efforts have concentrated on large-
scale functional analyses such a proteome-wide protein
interaction screens [12,13] or genome-wide siRNA knock-
downs [14-16], which are much more difficult to perform
and are notoriously unreliable [17-19]. Other approaches
such as ChIP-on-chip [20] and ChIP-Seq [21] are limited
to specific biological properties (e.g. DNA binding).
The relevance of this problem becomes apparent in exper-
iments that use large datasets such as in DNA microarray
hybridizations. Transcriptional profiling of a diseased
heart, for example, will identify changes in the expression
of known signaling pathways as well as genes, which do
not fit into existing regulatory circuits (see reviews [22]).
Although the expression profile of the latter group of
genes might correlate strongly with certain physiological
conditions or developmental status suggesting potential
interactions with known regulatory networks, reliable
data to describe the biological function are most often
missing.
Here, we describe a strategy for the systematic identifica-
tion of genes, which are correlated with a specific biolog-
ical condition (e.g. organ-specific expression) but lack
functional characterization. Our approach is based on the
systematic exploitation of existing databases such as the
UniGene database [23], which contain information about
organ-specific expression patterns, applying a number of
different filters. Information gathered from expression
databases were matched with publication records based
on the assumption that virtually all genes with a func-
tional characterization will also relay to a corresponding
publication. Although the focus of the study was on
"heart-enriched genes", our approach is applicable to vir-
tually all organs and physiological status. The expression
profiles of identified gene were validated by RT-PCR using
different murine adult organs and by whole-mount in situ
(WISH) hybridization of mouse embryos. The functional
role of selected genes was also approached by morpholino
knock-down experiments in zebrafish embryos
Results
In Silico Screening of UniGene Database
Several public databases for "omics" data are available,
which cover the expression profile of individual genes in
various organisms to a different extent. For our study, we
employed the UniGene database, which contains compre-
hensive coverage of various organisms and a collection of
expression data. Each UniGene ID has an attached
"Expression Profile", which can be used to search for spe-
cific expression sites. To identify genes in a systematic
manner, which show a preferential expression in the heart
but lack a proper functional annotation, we selected 4 dif-
ferent organisms for our analysis (rat, mouse, human, and
chicken) (Figure 1). Applying the rule "Select genes whose
rank for 'heart' is under the top 20% across homologues"
resulted in the identification of 2,348 mouse genes, which
fitted the rule in more than one organism. It should be
pointed out that the combination of expression data from
different organisms reduced the number of false-positive
candidates. Since the expression profile of genes is nor-
mally conserved among evolutionary close species, any
expression profile that is unique for a single species is
likely to indicate faulty expression profiling rather than a
biological meaningful result.
After identification of heart-enriched genes, we searched
for genes in this group, which lack a proper annotation.
We assumed that genes with no or very few publications
are "uncharacterized genes". To avoid papers describing
large screening efforts (e.g. microarrays, sequencing),
which usually do not include a functional analysis, we
excluded papers that contained more than 100 GeneIDs
(GI). Obviously, this selection is rather strict resulting in
exclusion of potentially interesting genes. To address this
problem, we added another selection criterion that was
based on Medical Subject Headings (MeSH). Inclusion of
the MeSH term for "heart" with less than 2 publications
resulted in the identification of 1,975 "uncharacterized"
mouse genes, which show an expression in the heart. Fig-
ure 2 depicts the numbers of heart-enriched genes, which
were identified using different combinations of organ-
isms. Selection of genes based on the concurrent expres-
sion in the heart in all  model organisms massively
decreased the number of positive genes yielding 124
heart-enriched genes of which 79 are uncharacterized.
Unfortunately, the quality of the expression data is not
identical in all model organisms, which resulted in exclu-
sion of genes, which have not been properly accessed but
in fact are expressed in the heart. An improvement of the
quality of the expression data will reduce the number of
false-negative genes in the future.BMC Genomics 2009, 10:100 http://www.biomedcentral.com/1471-2164/10/100
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Flowchart of in silico UniGene profile screening Figure 1
Flowchart of in silico UniGene profile screening. At the time of this study, 27,474 mouse GeneIDs (GI) with UniGene 
IDs were analyzed.BMC Genomics 2009, 10:100 http://www.biomedcentral.com/1471-2164/10/100
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Validation of the In Silico Screening
To demonstrate the efficiency of our method, we searched
the Gene Ontology project [24] for the term "heart" and
matched the results with our data set that was based on
the analysis of the expression data including genes, which
lack an annotation. We used 79 GO terms that contain the
phrase "heart" and screened the gene names and symbols
of the 4 selected model organisms. We found that 32 out
of the 79 GO terms contained at least one gene in the
organisms studied. The number of genes that were
obtained through our method and the coverage of GO
terms in percentages of the genes that matched our selec-
tion criteria are shown in Additional File 1. For example,
about 30% of the genes that carry the GO term "heart
development (GO:0007507)" were covered by our
method (34% for mouse, 28% for rat, 37% for human,
and 37% for chicken). The information about all 43
mouse genes that were extracted through our method
Venn diagram for heart-enriched genes Figure 2
Venn diagram for heart-enriched genes. The numbers of heart-enriched genes selected for the top 20% in the ranking of 
UniGene tissue expression profiles are shown for the 4 organisms analyzed and displayed as combinations of these organisms. 
In each combination, the number of genes with less than 2 articles after MeSH term filtering for "heart" is shown in parenthesis.BMC Genomics 2009, 10:100 http://www.biomedcentral.com/1471-2164/10/100
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using the GO term "heart development" is listed in Addi-
tional File 2.
Further Selection Rules to Eliminate Ubiquitously 
Expressed Genes
To validate the data obtained by our selection rules and to
confirm the database records, RT-PCR experiments using
mouse adult organs were performed. Surprisingly, we
found that a large number of genes were expressed in mul-
tiple organs (Figure 3A). We therefore devised a set of
additional rules to exclude ubiquitously expressed genes:
(i) Genes must be expressed in less than 50% of total tis-
sues; (ii) Sum of Gene EST must be less than 400; and (iii)
At least 25% of Gene EST must be expressed in the target
tissue (e.g. heart). Application of these rules efficiently
eliminated ubiquitously expressed genes and left genes
that were expressed preferentially in the heart (Figure 4B).
Interestingly, most of the genes that remained after this
selection were also expressed in striated muscles. This
result was not unexpected given the fact that skeletal mus-
cles and the heart are both composed of striated muscle
cells, which share numerous morphological and physio-
logical properties. Table 1 lists the number of mouse
genes that were identified by using the combination of
our selection rules. Inclusion of all three additional selec-
tion rules left only 30 mouse genes while inclusion of
selection rules (i) and (ii) left 920 genes. As shown in Fig-
ure 4B, inclusion of selection rules (i) and (ii) did already
efficiently exclude ubiquitously expressed genes. Addition
of the third selection rule did not improve massively the
number of genes with a heart-enriched expression pattern
but result in a general decrease of selected genes. The
inclusion of the third selection criterion proved to be
helpful only for some cases (data not shown).
Identification of Developmentally Expressed Genes
The expression in the adult heart does not necessarily
mean that the corresponding gene is also expressed during
early heart development. We therefore chose 20 genes
from the genes that emerged from the computational
screening and subjected them to whole-mount in situ
hybridization (WISH) using E10.5 and E11.5 mouse
embryos. At this stage, most organs have either formed or
undergo organogenesis. 18 out of the 20 genes showed
expression in the heart while 2 genes failed to display a
specific expression at these stages (Figure 4 and data not
shown). Based on the expression pattern, we distin-
guished two different groups: Group 1 showed equally
strong expression in the heart both at E10.5 and E11.5
(4632412N22Rik, A5530016L24Rik, Klhl31, Fsd2, Lrrc39,
and Rnf207); and Group 2 showed an increase of expres-
sion at E11.5 compared to E10.5 (Fhod3 and Lmod3).
Preliminary Functional Characterization of Selected Genes 
by Loss-of-Function in Zebrafish Embryos
To obtain initial functional data for the selected genes, we
turned to a loss-of-function analysis. Two uncharacter-
ized, heart-enriched genes were chosen: leucine rich
repeat containing 39 (Lrrc39) and kelch-like 31 (Dro-
sophila) (Klhl31). Lrrc39 is highly expressed in the adult
heart based on the RT-PCR analysis, and also found in
eyes, skeletal muscle, brown fat, and weakly in the stom-
ach (Figure 3B). During development, Lrrc39 is expressed
at E10.5 in the heart, in somites and in the eye anlagen
(Figure 4). Klhl31 showed a slightly different expression
pattern. It was expressed in the adult heart, brown fat,
skeletal muscle, and testes (Figure 3B). Klhl31 was also
detected very strongly in the heart during development at
E10.5 by WISH (Figure 4).
We decided to accomplish the loss-of-function analysis in
zebrafish embryos because knock-down of genes is rela-
tively easily achieved in zebrafish by injection of antisense
morpholinos. In addition, the development of the cardio-
vascular system in zebrafish embryos can be conveniently
monitored by microscopical inspections. The zebrafish
homologues of Lrrc39 and Klhl31 were identified using
HomoloGene [25] yielding "zgc:112088" and "klhl31"
(which are indicated as "zLrrc39" and "zKlhl31" respec-
tively). Morpholinos against "zLrrc39" and "zKlhl31" were
directed at their ATG sites.
zLrrc39  morphants showed the first signs of disturbed
development at 48 hour post fertilization (hpf). At 108
hpf, zLrrc39 morphants displayed a considerable pericar-
dial edema, which is a characteristic sign of cardiac mal-
functions (Figure 5A). All morphants died within 12
hours after this time point. To facilitate detection of devel-
opmental defects in the heart, we employed a transgenic
zebrafish line "Tg(myl7:EGFP-HRAS)s883" [26], in which
myocardial cells were labeled by GFP. Macroscopical eval-
uation of injected and control embryos at 48 hpf followed
by sectioning revealed a disturbed arrangement of cardio-
myocytes in the hearts of zLrrc39 morphants, but not in
control embryos, indicating a role of zLrrc39 in morpho-
genetic processes controlling heart development (Figure
5B, C). In addition, zLrrc39 morphants were characterized
by small eyes, malformations of the lower jaw, and dis-
torted muscle structures (Figure 5A). It was interesting to
note that the affected organs reflected the expression pro-
file of zLrrc39 during mouse development.
The knock-down of zKlhl31 resulted in a more severe phe-
notype compared to zLrrc39 essentially abrogating devel-
opment at 72 hpf. At 48 hpf, zKlhl31 morphants showed
cardiac and yolk sac edema as well as a distorted body axis
(Figure 5D). Sectioning of the heart of zKlhl31 morphantsBMC Genomics 2009, 10:100 http://www.biomedcentral.com/1471-2164/10/100
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RT-PCR results of selected genes Figure 3
RT-PCR results of selected genes. RT-PCR results of candidate genes derived without (A) and with (B) inclusion of addi-
tional selections rules described in materials and methods. The selection rules, which were applied for each of the analyzed are 
shown in (B) next to the images of the agarose gels. (C) Gapdh and Actb were used as loading controls. Water was used as a 
negative control for all reactions. With the exception of Gapdh and Actb (25 cycles), 28 amplification cycles were used.BMC Genomics 2009, 10:100 http://www.biomedcentral.com/1471-2164/10/100
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WISH results of selected genes Figure 4
WISH results of selected genes. Expression patterns of 8 representative genes are shown. Forelimbs were removed from 
E11.5 embryos to reveal the expression in the heart, if necessary.
Table 1: Combination of selection rules successively restricts the number of heart-enriched genes
Selection Category Number of Mouse Genes
Number of heart-enriched genes 2,348
With less than 2 publications in heart field in all 4 organisms 1,975
+ Mouse Further Rules 1 and others 926
+ Mouse Further Rules 1,2 or 1,2,3 920
+ Mouse Further Rules 1,2,3 30
The total numbers of genes that were identified using various combinations of selection tools are listed.BMC Genomics 2009, 10:100 http://www.biomedcentral.com/1471-2164/10/100
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revealed that ventricle morphogenesis was severely dis-
turbed, which essentially prevented looping of the heart.
Discussion
In the current study, we have devised a new strategy to
identify and characterize organ-specific gene, which lack a
detailed functional annotation. We reason that the identi-
fication and characterization of such genes will facilitate
future attempts to understand biological phenomena as a
collection of interconnected systems. Our approach was
based on a systematic exploitation of various databases
such as UniGene. UniGene is a NCBI's database system
for automatically partitioning GenBank sequences,
including ESTs, into a non-redundant set of gene-oriented
clusters [23]. Each UniGene cluster contains sequences
that represent a unique gene or expressed pseudogene,
together with related data sets including information
about tissue types in which the gene is expressed, model
organism protein similarities, and genomic locations. As
of May 2008, 97 species and thousands of sequence librar-
ies from various tissues were used to build UniGene clus-
ters. In principle, UniGene contains comprehensive
expression profiles based on sequencing results, which
can be used to obtain information about expression pat-
terns for a particular gene. UniGene also provides a cate-
gory called "Restricted Expression". In order for a
UniGene gene cluster to fall under this category, more
than half of the GenBank sequences assigned to the cluster
must come from the same source tissue. In Mus musculus,
there are only 34 gene clusters (e.g. Myh6,  Myh7, and
Nppa) listed under "Restricted Expression" in "heart",
which limits this application to genes that are not
expressed in any other tissue and restricts the usefulness of
this tool.
Loss-of-function phenotypes after morpholino injections Figure 5
Loss-of-function phenotypes after morpholino injections. (A) Effect of zLrrc39 at 108 hpf and (B) zKlhl31 morpholino 
injections on zebrafish development at 48 hpf, respectively. Lateral views of non-injected control (upper) and morphant 
(lower) embryos (Tg(myl7:EGFP-HRAS)s883) are shown. The arrow in (A) indicates the pericardial edema in injected zLrrc39 
morphant embryos. (C-E) Fluorescent images of heart sections at 48 hpf of control (C), zLrrc39 (D) and zKlhl31 (E) morphants 
are shown. Cardiomyocytes of zebrafish embryos were marked by expression of EGFP to delineate cellular morphology. Scale 
bar: 50 μm.BMC Genomics 2009, 10:100 http://www.biomedcentral.com/1471-2164/10/100
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To overcome the loss-of-information, which occurs when
applying such strict criteria, we developed selection rules
that are based on the conservation of expression profiles
of homologous genes between different species. This strat-
egy successfully enlarged the number of detected genes
without compromising the specificity of the detection.
Many studies have been conducted to identify tissue/
organ-specific genes with known and unknown functions
(reviewed extensively in [27]): endothelial [28]; epidi-
ymis [29-31]; heart [32-35]; mammary gland [34]; pan-
creas [34]; preimplantation stages [36,37]; prostate [38];
skeletal muscle [39]; and testis [40]. Other studies focused
on the discovery of biomarkers for diseases such as colon
[41] and prostate cancer [42]. Most of these studies uti-
lized cDNA or EST sequences and libraries from dbEST
[43] or UniGene to screen for tissue/organ-specific genes.
Some of these studies were validated by additional com-
putational methods while others used RT-PCR or North-
ern blotting experiments to confirm the initial database
searches. Only two studies included functional data
[33,35]. In contrast to previous studies, which restricted
the analysis to one or two species, we included four differ-
ent organisms to identify species-conserved, heart-
enriched expression patterns.
Several databases such as dbEST or UniGene [44-47] pro-
vide knowledge about tissue/organ-specific genes and give
information about expression in different organisms [48]
but are not particularly useful to serve as a starting point
for further functional studies of uncharacterized genes.
Our approach is simple and intuitive and does not require
extensive programming and computational knowledge.
We have demonstrated that DGSA (= Database-depend-
ent Gene Selection and Analysis) provides an efficient
means to select hitherto uncharacterized genes for further
functional analysis. Since our selection criteria strongly
relied on the conservation of expression profiles among
species, it was straightforward to turn to a functional anal-
ysis of identified genes using non-amniotes model organ-
isms such as zebrafish, which are particularly suited for
rapid functional characterization using morpholino injec-
tions to achieve a loss-of-function phenotype. Selected
genes might also be linked easily to databases of non-
amniotes model organisms such as the Zebrafish Model
Organisms Database (ZFIN) [49]. As of April 6, 2008, 89
zebrafish homologs of heart-enriched genes were
included in this database (data not shown). Of these, 25
(corresponds to 28% coverage) were linked to phenotypes
in heart or cardiac-related structures (e.g. cardioblast dif-
ferentiation, cardiac ventricle). Further efforts to charac-
terize mutants of genes, which were identified by DGSA in
amniotes, will certainly increase this coverage in the
future.
One might argue that a selection for conserved expression
patterns might artificially restrict the number of genes,
which can be detected or lead to the identification of
genes that are not involved in the development, mainte-
nance, or remodeling of the heart. To address this poten-
tial criticism, we matched the genes, which were identified
by our selection criteria with GO terms for known heart-
enriched genes. The fact that our algorithm provided 30%
or more coverage for genes that are known to be involved
in "heart development (GO:0007507)" clearly indicates
that our selection rules work efficiently even without per-
forming additional biological experiments. Although the
current study focused on heart-enriched genes, we rea-
soned that our selection rules might be easily extended to
other organs, such as brain, liver, spleen, and testis. In
fact, we found that application of our selection rules to the
above mentioned organs yielded the same coverage of GO
terms as for the heart (Additional File 3 for Venn diagrams
and Additional File 4 for GO coverage).
Conclusion
We have introduced an efficient way to screen for "heart-
enriched" genes with unknown functions. The computa-
tional approach to screen for genes across 4 species is sim-
ple and intuitive and might be applied by experimental
biologists without programming knowledge. The pre-
sented strategy can be easily extended by implementing
expression information about developing embryos
obtained through public microarray and SAGE databases.
Further functional analysis of identified genes will help to
fill the gaps in our knowledge, which prevents a compre-
hensive understanding of complex molecular interactions
as intended by "Systems Biology" researchers.
Methods
In the following section, all dataset names are indicated
by quotation marks.
Selection Rules for UniGene Profiles
The data sources for all datasets used in this study are
listed in Additional File 5 including the FTP sites, dates of
data retrievals, and version numbers, if applicable. As a
starting point, UniGene's "Mm.data" was used to search
for the number of mouse GeneIDs (GI) with UniGene
IDs. Next, HomoloGene's "homologene.data", was used
to search for homologs and their UniGene IDs in rat (Rat-
tus norvegicus; Taxonomy ID 10116), human (Homo
sapiens; Taxonomy ID 9606), and chicken (Gallus gallus;
Taxonomy ID 9031). The UniGene tissue expression pro-
files ("Mm.profiles" for mouse, "Rn.profiles" for rat,
"Hs.profiles" for human, and "Gga.profiles" for chicken)
were screened with the selection rule: "Select genes whose
rank for 'heart' is under the top 20% across homologs." At
the time of the screening, the number of tissues for each
organism and the definition of the top 20% were as fol-BMC Genomics 2009, 10:100 http://www.biomedcentral.com/1471-2164/10/100
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lows (organism name, number of tissues, number of tis-
sues that fall under the top 20% category): Mouse, 47, 9;
Rat, 25, 5; Human, 45, 9; and Chicken, 18, 4. Selected
genes were subjected to the following further selection
rules to eliminate ubiquitously expressed genes in mouse:
(i) Expressed in less than 50% of total tissues. (ii) Sum of
Gene EST must be less than 400. (iii) At least 25% of Gene
EST must be expressed in the target tissue. A flowchart of
the UniGene in silico screening procedure is given in Fig-
ure 1.
Identification of Publications Corresponding to GIs
To find the number of publications related to an identi-
fied gene, Entrez Gene's "gene2pubmed" was used. First,
the number of GIs that are listed under each PMID was
counted and classified. Publications that include more
than 100 GIs were considered as articles that report large
screening results (e.g. microarrays, sequencing) and
excluded to be counted for the number of publications for
each gene. Next, PMIDs whose classification in Medical
Subject Headings (MeSH) is under "heart" were searched
and cross matched to the number of publications for each
gene. If this number was less than 2, the GI (gene) was
defined as being "uncharacterized".
Searching for Genes with GO Terms Related to Heart
Gene Ontology [24] terms for "heart" were searched
through AmiGO [50]. Next, using these GO terms, gene
names and their symbols were extracted from Entrez
Gene's "gene2go".
To demonstrate the statistical significance of GO coverage,
Fisher's exact test was applied. First, numbers of genes
with at least one GO term were computed from Entrez
Gene's "gene2go", which resulted in 18,225 genes for
mouse, 16,437 for rat, 17,905 for human, and 9,226 for
chicken. Then, a Fisher's exact test was applied to 2,348
heart-enriched genes for each GO term and its coverage.
RNA Preparation, First-Strand cDNA Synthesis and RT-
PCR
To extract total RNA, adult mice were sacrificed, and
washed extensively with ice-cold PBS to remove blood.
Isolated organ parts were frozen in liquid nitrogen and
homogenized using TRIzol Reagent (Invitrogen). 2 μg of
purified RNA was reverse transcribed using SuperScript II
First-Strand Synthesis System (Invitrogen) to synthesize
the first-strand cDNA by following the manufacturer's
protocol. First-strand cDNA was diluted with water to gen-
erate a 1:5 dilution. 1 μl of cDNA was used for each PCR
reaction. The following thermal profile was used for all
PCR experiments: 95°C for 2 minutes, denaturation
(94°C) for 30 seconds, annealing (60–64°C) for 30 sec-
onds, extension (72°C) for 1 minute, followed by a final
extension (72°C) for 7 minutes. Amplified PCR products
were separated in 2% agarose gel and visualized using UV
light.
Whole-Mount In Situ Hybridization
To generate RNA probes, PCR amplified products were
purified from the gel and cloned using pGEM-T Easy Sys-
tem (Promega). Antisense RNA probes were labeled with
digoxigenin-UTP (Roche), using SP6 or T7 RNA polymer-
ase (Promega). Embryos were fixed in 4% paraformalde-
hyde (PFA) dissolved in PBS/DEPC-treated water
overnight and dehydrated the next day with 25%, 50%,
75%, and 100% methanol. For whole-mount in situ
hybridizations, published protocols were used [51] with
minor modifications. After staining, embryos were post-
fixed in 4% PFA and stored at 4°C until photographs were
taken.
Morpholino Injection
The zebrafish strains used in this study were "Bad
Nauheim (BNA)", which was originated from a local pet
shop and was inbred for several generations, and
"Tg(myl7:EGFP-HRAS)s883" [25]. Antisense morpholinos
were purchased from BioCat (Clone ID MORPH 1769 for
zLrrc39) and GeneTools (zKlhl31). For the morpholino
experiments, 3 concentrations were tested (approximately
2–4 nl of morpholino diluted in sterile water/phenol red
as an indicator per zebrafish egg): "1:2 dilution (high)",
which corresponds to 8.5–17 ng of morpholino; "1:5
dilution (medium)", 3.4–6.8 ng; and "1:10 dilution
(low)", 1.7–3.4 ng. For each injection, more than 50 eggs
were injected. As a control, sterile water/phenol red with-
out morpholino was used to observe effects caused by the
injection.
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